CuePath Innovations Inc.
Vancouver, CA · 2 known investors
CuePath makes smart adhesive stickers (CuePack) that attach to standard medication blister packs, recording when each blister is opened and syncing that adherence data to the cloud and clinical trial management systems such as REDCap. The product serves clinical researchers and contract research organizations running distributed, placebo-controlled drug trials, particularly for controlled substances and substance use disorder treatment.
Also known as CuePath · CuePath Innovation
Investors · 2
Company profile
researched Aug 2026CuePath Innovation is a Vancouver, British Columbia-based provider of technology for monitoring and improving medication adherence. Its flagship product, the CuePack, is a printed-electronics smart sticker (also referred to as CueStickers) that attaches to commonly available medication blister packs and automatically records the date and time each blister is opened, replacing participant self-reporting in drug studies. Data from the sticker is transmitted to CuePath's secure cloud gateway and synced with contract research organization (CRO) clinical trial management software.
The system is positioned for large, distributed, placebo-controlled drug trials, with an initial design focus on addiction and pain management studies and on trials involving controlled substances or high-value pill-based drugs. The company states the technology addresses four industry challenges: improving safety and dosage accuracy, reducing study burden by avoiding daily witnessed ingestion, enhancing reliability of efficacy analysis, and preventing diversion of controlled substances. Additional stated benefits include reduced need for in-clinic visits, support for trials with hundreds of distributed participants, and no required behaviour change for blister pack users. CuePath states that no identifying patient information passes through its servers.
Business model
CuePath supplies its sticker hardware together with cloud data collection and integration services to organizations running clinical trials, including customizable data exports and integration work for the customer's trial data platform.
Traction
CuePath's stickers are being used in the ASCME clinical trial for methamphetamine use disorder treatment, a pan-Canadian multisite study funded by Health Canada and led by the University of Montreal Hospital Research Centre (CRCHUM), supported in partnership with ChangeMark Research + Evaluation.
▸Full profile — market position, technology, go-to-market, geography
Market position
A small Canadian medication-adherence technology vendor serving clinical trial sponsors and CROs, currently anchored by a single publicly described pan-Canadian trial deployment.
CuePath positions the product as attaching to standard, commonly available blister packs rather than requiring specialized packaging or behaviour change, providing objective real-time adherence timestamps in place of self-reporting, and keeping patient-identifying information off its servers.
Technology
Printed electronic adhesive stickers applied to standard blister packs detect and timestamp each blister opening. Readings are transmitted to CuePath's cloud gateway and synced to clinical trial management systems, including REDCap and proprietary or third-party platforms, with customizable data export formats and conversion into different systems and workflows.
Go-to-market
The company works through CRO partnerships, notably BC-based ChangeMark Research + Evaluation, and through participation in funded academic trials, and states a 2025 objective of expanding partnerships in North America's mental health and substance use clinical trial research communities.
Clinical researchers, contract research organizations, and academic or government-funded trial sponsors, particularly in mental health, substance use disorder, addiction and pain management research.
Geography
Headquartered in Vancouver, British Columbia, Canada, with product designed and developed locally; trial deployment is pan-Canadian and the company targets opportunities across North America.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 1
launches, deals, and filingsCuePath supports the ASCME clinical trial for methamphetamine use disorder treatment, a pan-Canadian multisite study funded by Health Canada and led by the University of Montreal Hospital Research Centre (CRCHUM), in partnership with BC-based CRO ChangeMark Research + Evaluation.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 2
primary sources listed
- CuePath Innovations Inc.cuepath.com · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does CuePath Innovations Inc. do?
- Vancouver-based CuePath makes smart stickers for medication blister packs that record dose events for clinical trials.
- Who are CuePath Innovations Inc.'s investors?
- CuePath Innovations Inc.'s investors include Angel Forum, WUTIF Capital.
- Where is CuePath Innovations Inc. headquartered?
- CuePath Innovations Inc. is headquartered in Vancouver, CA.